Chronic kidney disease (CKD) is a growing problem in many parts of the world, with >700 million people affected.1 One of the main challenges in the…

Membranous nephropathy (MN) is the major cause of nephrotic syndrome in adults, accounting for 20% of cases with an annual incidence of 1 per 100,000 population.

INJURY to renal cells can lead to the development of papillary renal cell carcinoma (RCC) via the kidney’s own repair mechanisms. Leading nephrologist…

CHRONIC kidney disease (CKD), a long-term condition resulting in the gradual loss of kidney function, is surrounded by debate regarding validity…

Prolonged intermittent renal replacement therapy (PIRRT) is emerging as an alternative to continuous renal replacement therapy as renal support for the critically ill.

Eosinophilic granulomatosis with polyangiitis (EGPA) is a small vessel vasculitis characterised by the presence of tissue eosinophilia…

Acute kidney injury (AKI) is a major global health problem, occurring in >13 million people and responsible for >2.3 million deaths every year, 85% of which are in developing countries.

Rituximab (RTX) is used worldwide for the treatment of glomerulonephritis (GN), including membranous glomerulopathy (MN), minimal change disease (MCD)…

Diabetic kidney disease (DKD) is defined as a clinical syndrome consisting of persistent macroalbuminuria

Prolonged intermittent renal replacement therapy (PIRRT) is an emerging form of renal replacement therapy in critically ill patients, but dosing data…